IXICO plc and VirtualScopics, Inc. jointly announced today that the Scientific Advisory Board (SAB), formed as an initiative of the companies’ Alliance Framework signed in June, met for the first time in Philadelphia, Pennsylvania on December 11, 2014.
Each member of the board provided a report on state of the art technologies and solutions in his particular area of imaging expertise, including both threats and opportunities for the Alliance to consider in 2015 and beyond. Therapeutic areas represented included Oncology, Hematology, Muscular Disease, Metabolic Disorders, Cardiology, and Neurology.
Dr. Edward Ashton, Ph.D., Chief Scientific Officer for VirtualScopics and Chairman of the SAB, noted that:
“This was a great first meeting. The presentations were on-point and informative, and the discussions among the members afterward were very helpful in solidifying our technical goals for the coming year.”
Derek Hill, PhD, CEO of IXICO added:
“Drug development is a rapidly evolving landscape and this SAB helps us plan how to develop our technology, products and services to meet the changing needs of our customers.”
For more information on VirtualScopics, Inc. please visit www.virtualscopics.com.